Federal contract award
HHSO100201500022C
IGF::CT::IGF FIRST LIGHT BIOSCIENCES, INC.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $30.2M |
| Current contract value | $41.4M |
| Potential contract value / ceiling | $41.4M |
| Start date | Sep 30, 2015 |
| Current end date | Nov 30, 2023 |
| Potential end date | Nov 30, 2023 |
| Latest award activity | Aug 12, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 12, 2025 | P00029 | $-15.4K | DE-OBLIGATE $15,438.10 AND CLOSEOUT THE CONTRACT IN ITS ENTIRETY. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.